Impact of phenolic-rich olive leaf extract on blood pressure, plasma lipids and inflammatory markers: a randomised controlled trial

European Journal of Nutrition

Volumn 56, Issue 4, 2017, Pages 1421-1432

  Lockyer, Stacey ^a   Rowland, Ian ^a   Spencer, Jeremy Paul Edward ^a   Yaqoob, Parveen ^a   Stonehouse, Welma ^b,c  

^a UNIVERSITY OF READING   (United Kingdom)

^b MASSEY UNIVERSITY   (New Zealand)

^c CSIRO   (Australia)

Author keywords

Blood pressure; Cardiovascular disease; Oleuropein; Olive leaf; Plasma lipids; Polyphenols

Indexed keywords

ACTEOSIDE; ADIPONECTIN; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; APIGETRIN; C REACTIVE PROTEIN; CHOLESTEROL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FRUCTOSAMINE; GLUCOSE; HYDROXYTYROSOL; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEOLIN; LUTEOLIN 7 GLUCOSIDE; OLEOSIDE; OLEUROPEIN; OLIVE LEAF EXTRACT; OXIDIZED LOW DENSITY LIPOPROTEIN; PHENOL DERIVATIVE; PLANT EXTRACT; RUTOSIDE; TRIACYLGLYCEROL; TYROSOL; UNCLASSIFIED DRUG; VANILLIC ACID; VANILLIN; VASCULAR CELL ADHESION MOLECULE 1; BIOLOGICAL MARKER; CYTOKINE; IRIDOID; POLYPHENOL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTERIAL STIFFNESS; ARTICLE; AUGMENTATION INDEX; BIOCHEMICAL ANALYSIS; BLOOD PRESSURE; BLOOD VESSEL FUNCTION; BODY COMPOSITION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EVIDENCE BASED PRACTICE; GLUCOSE METABOLISM; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; INTERVENTION STUDY; LIPID BLOOD LEVEL; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; NORMAL HUMAN; OLIVE TREE; PATIENT COMPLIANCE; PREHYPERTENSION; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; AGED; BLOOD; BODY MASS; CHEMISTRY; DRUG EFFECTS; METABOLISM; PLANT LEAF; RISK FACTOR; YOUNG ADULT;

ADULT; AGED; BIOMARKERS; BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; CHOLESTEROL; CROSS-OVER STUDIES; CYTOKINES; DOUBLE-BLIND METHOD; HUMANS; INFLAMMATION; IRIDOIDS; MALE; MIDDLE AGED; OLEA; PLANT EXTRACTS; PLANT LEAVES; POLYPHENOLS; RISK FACTORS; TRIGLYCERIDES; YOUNG ADULT;

EID: 84960111758     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-016-1188-y     Document Type: Article

References (62)

1. López-Miranda J, Pérez-Jiménez F, Ros E et al (2010) Olive oil and health: summary of the II international conference on olive oil and health consensus report, Jaén and Córdoba (Spain) 2008. Nutr Metab Cardiovasc Dis 20:284–294
2. Barzi F, Woodward M, Marfisi R et al (2003) Mediterranean diet and all-causes mortality after myocardial infarction: results from the GISSI-Prevenzione trial. Eur J Clin Nutr 57:604–611
3. Cicerale S, Lucas L, Keast R (2010) Biological activities of phenolic compounds present in virgin olive oil. Int J Mol Sci 11:458–479
4. Ramirez-Tortosa MC, Urbano G, López-Jurado M et al (1999) extra-virgin olive oil increases the resistance of LDL to oxidation more than refined olive oil in free-living men with peripheral vascular disease. J Nutr 129:2177–2183
5. Marrugat J, Covas M-I, Fitó M et al (2004) Effects of differing phenolic content in dietary olive oils on lipids and LDL oxidation. Eur J Nutr 43:140–147. doi:10.1007/s00394-004-0452-8
6. Silva S, Gomes L, Leitao F et al (2006) Phenolic compounds and antioxidant activity of Olea europaea L. fruits and leaves. Food Sci Technol Int 12:385–395
7. Kountouri AM, Mylona A, Kaliora AC et al (2007) Bioavailability of the phenolic compounds of the fruits (drupes) of Olea europaea (olives): impact on plasma antioxidant status in humans. Phytomedicine 14:659–667
8. Owen RW, Mier W, Giacosa A et al (2000) Phenolic compounds and squalene in olive oils: the concentration and antioxidant potential of total phenols, simple phenols, secoiridoids, lignansand squalene. Food Chem Toxicol 38:647–659. doi:10.1016/S0278-6915(00)00061-2
9. Petkov V, Manolov P (1972) Pharmacological analysis of the iridoid oleuropein. Arzneim Forsch (Drug Res) 22:1476–1488
10. Lockyer S, Yaqoob P, Spencer J et al (2012) Olive leaf phenolics and cardiovascular risk reduction: physiological effects and mechanisms of action. Nutr Aging 1:125–140
11. Perrinjaquet-Moccetti T, Busjahn A, Schmidlin C et al (2008) Food supplementation with an olive (Olea europaea L.) leaf extract reduces blood pressure in borderline hypertensive monozygotic twins. Phytother Res 22:1239–1242. doi:10.1002/ptr.2455
12. Cherif N, Rahal M, Haouala B, Hizaoui F, Dargouth M, Gueddiche Z, Kallel G, Balansard G, Boukef K (1996) A clinical trial of a titrated Olea extract in the treatment of essential arterial hypertension. J Pharm Belg 51:69–71
13. Susalit E, Agus N, Effendi I et al (2011) Olive (Olea europaea) leaf extract effective in patients with stage-1 hypertension: comparison with Captopril. Phytomedicine 18:251–258
14. Fonollá J, Díaz-Ropero P, de la Fuente E et al (2010) MS358 One-month consumption of an olive leaf extract enhances cardiovascular status in hypercholesterolemic subjects. Atheroscler Suppl 11:182
15. Filip R, Possemiers S, Heyerick A et al (2015) Twelve-month consumption of a polyphenol extract from olive (Olea europaea) in a double blind, randomized trial increases serum total osteocalcin levels and improves serum lipid profiles in postmenopausal women with osteopenia. J Nutr Health Aging 19:77–86. doi:10.1007/s12603-014-0480-x
16. Lockyer S, Corona G, Yaqoob P et al (2015) Secoiridoids delivered as olive leaf extract induce acute improvements in human vascular function and reduction of an inflammatory cytokine: a randomised, double-blind, placebo-controlled, cross-over trial. Br J Nutr 114:75–83
17. Esposito K, Marfella R, Ciotola M et al (2004) Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome. JAMA J Am Med Assoc 292:1440–1446. doi:10.1001/jama.292.12.1440
18. Fuentes F, López-Miranda J, Sánchez E et al (2001) Mediterranean and low-fat diets improve endothelial function in hypercholesterolemic men. Ann Intern Med 134:1115–1119
19. Ryan M, McInerney D, Owens D et al (2000) Diabetes and the Mediterranean diet: a beneficial effect of oleic acid on insulin sensitivity, adipocyte glucose transport and endothelium-dependent vasoreactivity. QJM 93:85–91. doi:10.1093/qjmed/93.2.85
20. Moreno-Luna R, Muñoz-Hernandez R, Miranda ML et al (2012) Olive oil polyphenols decrease blood pressure and improve endothelial function in young women with mild hypertension. Am J Hypertens 25:1299–1304
21. Ruano J, Lopez-Miranda J, Fuentes F et al (2005) Phenolic content of virgin olive oil improves ischemic reactive hyperemia in hypercholesterolemic patients. J Am Coll Cardiol 46:1864–1868
22. de Bock M, Derraik JG, Brennan CM et al (2013) Olive (Olea europaea L.) leaf polyphenols improve insulin sensitivity in middle-aged overweight men: a randomized, placebo-controlled, crossover trial. PLoS One 8:e57622
23. Gt M (2005) Lowering blood pressure for cardiovascular risk reduction. J Hypertens Suppl 23:S3–S8
24. EFSA (2011) Guidance on the scientific requirements for health claims related to antioxidants, oxidative damage and cardiovascular health. EFSA J 9:2474–2487
25. Laurent S, Boutouyrie P, Asmar R et al (2001) Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37:1236–1241
26. Tanaka H, Munakata M, Kawano Y et al (2009) Comparison between carotid-femoral and brachial-ankle pulse wave velocity as measures of arterial stiffness. J Hypertens 27:2022–2027
27. Karatzi KPC, Karatzis E, Papaioannou T, Aznaouridis K, Katsichti P, Stamatelopoulos K, Zampelas A, Lekakis J, Mavrikakis M (2005) Red wine acutely induces favorable effects on wave reflections and central pressures in coronary artery disease patients. Am J Hypertens 18:1161–1167
28. Vlachopoulos CAN, Dima I, Aznaouridis K, Andreadou I, Stefanadis C (2006) Acute effect of black and green tea on aortic stiffness and wave reflections. J Am Coll Nutr 25:216–223
29. Yasmin BM (1999) Similarities and differences between augmentation index and pulse wave velocity in the assessment of arterial stiffness. QJM 92:595–600
30. Wilkinson IBMH, Flint L, Cockcroft J, Newby D, Webb D (2000) The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol 525:263–270
31. Chobanian AV, Bakris GL, Black HR et al (2003) The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. J Am Med Assoc 289:2560–2571
32. New Zealand Guidelines Group (2009) New Zealand cardiovascular guidelines handbook: a summary resource for primary care practitioners, 2nd edn. New Zealand Guidelines Group, Wellington
33. Cook NR, Cohen J, Hebert PR et al (1995) Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med 155:701–709. doi:10.1001/archinte.1995.00430070053006
34. Neutel JM (2006) The role of combination therapy in the management of hypertension. Nephrol Dial Transplant 21:1469–1473. doi:10.1093/ndt/gfk064
35. Rauwald HW, Brehm O, Odenthal KP (1994) Screening of nine vasoactive medicinal plants for their possible calcium antagonistic activity. Strategy of selection and isolation for the active principles of Olea europaea and Peucedanum ostruthium. Phytother Res 8:135–140. doi:10.1002/ptr.2650080303
36. 2+ channel antagonistic effects. J Ethnopharmacol 120:233–240
37. Kang DG, Lee YS, Kim HJ et al (2003) Angiotensin converting enzyme inhibitory phenylpropanoid glycosides from Clerodendron trichotomum. J Ethnopharmacol 89:151–154. doi:10.1016/S0378-8741(03)00274-5
38. Hansen K, Adsersen A, Christensen SB et al (1996) Isolation of an angiotensin converting enzyme (ACE) inhibitor from Olea europaea and Olea lancea. Phytomedicine 2:319–325
39. Bock M, Thorstensen EB, Derraik JG et al (2013) Human absorption and metabolism of oleuropein and hydroxytyrosol ingested as olive (Olea europaea L.) leaf extract. Mol Nutr Food Res 57:2079–2085
40. Conway J, Johnston J, Coats A et al (1988) The use of ambulatory blood pressure monitoring to improve the accuracy and reduce the numbers of subjects in clinical trials of antihypertensive agents. J Hypertens 6:111–116
41. Ruano J, López-Miranda J, de la Torre R et al (2007) Intake of phenol-rich virgin olive oil improves the postprandial prothrombotic profile in hypercholesterolemic patients. Am J Clin Nutr 86:341–346
42. Perona JS, Cabello-Moruno R, Ruiz-Gutierrez V (2006) The role of virgin olive oil components in the modulation of endothelial function. J Nutr Biochem 17:429–445
43. Carluccio MA, Massaro M, Scoditti E et al (2007) Vasculoprotective potential of olive oil components. Mol Nutr Food Res 51:1225–1234. doi:10.1002/mnfr.200600305
44. Tsimidou MZ, Papoti VT (2010) Bioactive ingredients in olive leaves. In: Preedy VR (ed) Olives and olive oil in health and disease prevention. Elsevier Inc, London, pp 349–356
45. Somova LI, Shode FO, Ramnanan P et al (2003) Antihypertensive, antiatherosclerotic and antioxidant activity of triterpenoids isolated from Olea europaea, subspecies africana leaves. J Ethnopharmacol 84:299–305
46. Gould AL, Rossouw JE, Santanello NC et al (1998) cholesterol reduction yields clinical benefit: impact of statin trials. Circulation 97:946–952. doi:10.1161/01.cir.97.10.946
47. Mihaylova B, Emberson J, Blackwell L et al (2012) The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 380:581–590. doi:10.1016/s0140-6736(12)60367-5
48. Hokanson JE, Austin MA (1996) Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a metaanalysis of population-based prospective studies. J Cardiovasc Risk 3:213–219. doi:10.1177/174182679600300214
49. Lee J-S, Choi M-S, Jeon S-M et al (2001) Lipid-lowering and antioxidative activities of 3,4-di(OH)-cinnamate and 3,4-di(OH)-hydrocinnamate in cholesterol-fed rats. Clin Chim Acta 314:221–229
50. Krzeminski R, Gorinstein S, Leontowicz H et al (2003) Effect of different olive oils on bile excretion in rats fed cholesterol-containing and cholesterol-free diets. J Agric Food Chem 51:5774–5779. doi:10.1021/jf030088a
51. Liu J, Rajendram R, Zhang L (2010) Effects of oleanolic acid and maslinic acid on glucose and lipid metabolism: implications for the beneficial effects of olive oil on health. In: Preedy VR (ed) Olives and olive oil in health and disease prevention. Elsevier Inc, London, pp 1423–1429
52. Dibbs Z, Thornby J, White BG et al (1999) Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: implications for clinical trials. J Am Coll Cardiol 33:1935–1942. doi:10.1016/s0735-1097(99)00130-8
53. Rizza L, Munafo S, Serraino A (2012) Compositions for the treatment of hemorrhoids and related diseases. http://www.google.com/patents/US20120183627
54. Impellizzeri D, Esposito E, Mazzon E et al (2011) Oleuropein aglycone, an olive oil compound, ameliorates development of arthritis caused by injection of collagen type II in mice. J Pharmacol Exp Ther 339:859–869
55. Miles EA, Zoubouli P, Calder PC (2005) Differential anti-inflammatory effects of phenolic compounds from extra virgin olive oil identified in human whole blood cultures. Nutrition 21:389–394
56. Boekholdt SM, Peters RJ, Hack CE et al (2004) IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women the EPIC-norfolk prospective population study. Arterioscler Thromb Vasc Biol 24:1503–1508
57. Shin WS, Szuba A, Rockson SG (2002) The role of chemokines in human cardiovascular pathology: enhanced biological insights. Atherosclerosis 160:91–102
58. D’Agostino RB Sr, Pencina MJ, Massaro JM et al (2013) Cardiovascular disease risk assessment: insights from Framingham. Glob Heart 8:11–23. doi:10.1016/j.gheart.2013.01.001
59. Komaki EYS, Maru I, Kinoshita M, Kakehi K, Ohta Y, Tsukada Y (2003) Identification of anti-α-amylase components from olive leaf extracts. Food Sci Technol Res 9:35–39
60. Fito M, Cladellas M, de la Torre R et al (2008) Anti-inflammatory effect of virgin olive oil in stable coronary disease patients: a randomized, crossover, controlled trial. Eur J Clin Nutr 62:570–574. doi:10.1038/sj.ejcn.1602724
61. Committee Guidelines (2003) European Society of Hypertension–European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 21:1011–1053
62. National Institute of Health and Care Excellence (2014) Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. http://www.nice.org.uk/guidance/CG181/chapter/1-Recommendations#lifestyle-modifications-for-the-primary-and-secondary-prevention-of-cvd